Home / Technical Content / Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis
Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis
Unlock the Future of RNA Manufacturing
With Enzymatic Synthesis
Traditional solid-phase oligonuclueotide synthesis is struggling to keep pace with today’s increasing demands for RNA therapeutics. That’s why many developers are turning to enzyme-enabled RNA synthesis — a sustainable approach that’s designed to scale.
This ebook unpacks how this strategy is driving real results:
- Cutting timelines with modular, parallel workflows
- Supporting scalability beyond a 10 kg batch size
- Improving yield while reducing environmental burden
- Reducing purification of duplex RNA
These results are achieved using two key methods: ligation-based assembly of RNA fragments or fully sequential RNA synthesis. See how leading drug developers are using these innovations to de-risk development and accelerating development time.
Gated content
Please complete the form below to access this content.
Discover the Expertise Powering Possibility
Speak to our experts to learn how our platforms deliver smarter science, faster timelines, and greater confidence. Let’s talk.
Related content
Machine learning-guided ligation fragment design for efficient siRNA synthesis
Comparative analysis of diastereomeric distribution in siRNA synthesis: SPOS vs enzymatic synthesis
Oligonucleotide CMC for sustainable and scalable enzymatic siRNA manufacturing
Want to see more technical content?
We're Paving Your Path to the Future
You own the product and we own the path. Together, we’ll take it to market clearly, cleanly and without surprises.